| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 04/13/2005 | CN1196682C 4-pyridinyl-N-acyl-L-phenylalanines |
| 04/13/2005 | CN1196673C (-)-Verbenzone derivs. |
| 04/13/2005 | CN1196481C Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 04/13/2005 | CN1196479C Use of benzidine prostaglandins of inhalation form |
| 04/13/2005 | CN1196478C Combinations of formoterol and mometasone furoate for asthma |
| 04/13/2005 | CN1196475C Bioavailable dosage form of isotretinoin |
| 04/12/2005 | US6878828 Coupling cysteine with benzonitrile, then esterifying, alkylating, hydrolyzing and reacting with acids to form 2-methylcysteine |
| 04/12/2005 | US6878751 Administration of resveratrol to treat inflammatory respiratory disorders |
| 04/12/2005 | US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough |
| 04/12/2005 | US6878730 Especially (2R)-N-(1-(6-aminopyridin-2-ylmethyl)1-methyl-piperdin-4-yl)-2-((1R)-3,3, -difluorocyclopentyl)-2-hydroxy-2-phenylacetamide iodide; treating asthma, chronic obstructive pulmonary disorder and allergic or infectious rhinitis |
| 04/12/2005 | US6878726 For therapy and prophylaxis inflammation, other inflammation associated disorders, such as arthritis, neurodegeneration and colon cancer, in mammals, dogs, cats or livestock animals |
| 04/12/2005 | US6878725 Serine protease inhibitors |
| 04/12/2005 | US6878721 Beta2-adrenoceptor agonists |
| 04/12/2005 | US6878714 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer |
| 04/12/2005 | US6878711 Indole derivatives as PDE5-inhibitors |
| 04/12/2005 | US6878709 Treating acute and chronic inflammatory disorders and cancer. |
| 04/12/2005 | US6878702 Anti-inflammatory agents |
| 04/12/2005 | US6878701 Potassium channel blocking agents |
| 04/12/2005 | US6878529 Compounds for the treatment of sexual dysfunction |
| 04/12/2005 | US6878522 Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2 |
| 04/12/2005 | US6878387 Core with an organic acid salt; acrylic blend coating of an interpolymer of a (meth)acrylate ester and a quaternary ammonium (meth)acrylate and a (meth)acrylate ester homo- or copolymer with an ester having acid or base groups |
| 04/12/2005 | CA2267994C Truncated platelet-activating factor acetylhydrolase |
| 04/12/2005 | CA2203936C Boronic ester and acid compounds, synthesis and uses |
| 04/12/2005 | CA2194471C Bis-piperidinyl non-peptidyl tachykinin receptor antagonist |
| 04/07/2005 | WO2005030955A1 Protein expressed in nk cell |
| 04/07/2005 | WO2005030773A1 Novel pyrazolopyrimidine derivatives |
| 04/07/2005 | WO2005030725A1 Derivatives of 3-aminocarbonylquinoline, pharmaceutical compositions containing them and processes and intermediates for their preparation |
| 04/07/2005 | WO2005030331A1 Combination antihistamine medication |
| 04/07/2005 | WO2005030252A1 Treatment of respiratory diseases with anti-il-2 receptor antibodies |
| 04/07/2005 | WO2005030245A1 Inhibition of fractalkine or of its receptor for the treatment of atopic allergic diseases |
| 04/07/2005 | WO2005030220A1 Pulmonary disease treatment |
| 04/07/2005 | WO2005030212A1 4-aminoquinoline-3-carboxamide derivatives as pde4 inhibitors |
| 04/07/2005 | WO2005012269A8 Novel azole compound |
| 04/07/2005 | WO2004089348A3 Use of a serotonin transporter inhibitor for the treatment of pulmonary hypertension |
| 04/07/2005 | WO2003064458A8 Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof |
| 04/07/2005 | US20050075394 Phenethanolamine derivatives for treatment of respiratory diseases |
| 04/07/2005 | US20050075385 Substituted thienoimidazoles useful for disease treatment and prevention |
| 04/07/2005 | US20050075373 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 04/07/2005 | US20050075346 Novel compounds |
| 04/07/2005 | US20050075334 Novel compounds |
| 04/07/2005 | US20050075271 Crystalline beta2 adrenergic receptor agonist |
| 04/07/2005 | US20050074841 DNAs encoding mammalian histamine receptor of the H4 subtype |
| 04/07/2005 | US20050074797 FHIT proteins and nucleic acids and methods based thereon |
| 04/07/2005 | US20050074775 assessing GST-pi expression levels in fixed or fixed and paraffin embedded tissues using primers; pharmacogenetics; determining antitumor platinum-based chemotherapeutic regimen |
| 04/07/2005 | US20050074770 Cloned mammalian histamine H4 receptor that couples to G-protein; for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 04/07/2005 | US20050074751 Binding viral protein during latency life cycle; binding of antibodies to excellular segments of protein; immobilization; removal of infecting cells; autoimmune disease, lupus, antiarthritic agents |
| 04/07/2005 | US20050074498 Perforated microstructure; flowability, dispersibility; stable aerosols; respiratory inhalants |
| 04/07/2005 | US20050074436 Systems and methods for treating patients with processed lipoaspirate cells |
| 04/07/2005 | DE10341923A1 Verwendung von Tolperison Use of Tolperisone |
| 04/07/2005 | DE10341240A1 Substituierte Thienoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament Substituted Thienoimidazole, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing |
| 04/07/2005 | CA2540701A1 Proteins expressed in nk cells |
| 04/07/2005 | CA2540005A1 Pulmonary disease treatment |
| 04/07/2005 | CA2538737A1 Treatment of respiratory diseases with anti-il-2 receptor antibodies |
| 04/07/2005 | CA2538037A1 Amino-substituted ethylamino .beta.2 adrenergic receptor agonists |
| 04/06/2005 | EP1520586A1 Inhibition of fractalkine or of its receptor for the treatment of atopic allergic diseases |
| 04/06/2005 | EP1520043A2 METHODS FOR THE IDENTIFICATION OF IKKa FUNCTION AND OTHER GEN ES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES |
| 04/06/2005 | EP1519956A2 Epha2 monoclonal antibodies and methods of use thereof |
| 04/06/2005 | EP1519933A1 Quinuclidine amide derivatives |
| 04/06/2005 | EP1519923A1 Novel benzimidazol-2-one derivatives and their use |
| 04/06/2005 | EP1519922A1 Di-aryl-substituted ethane pyridone pde4 inhibitors |
| 04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
| 04/06/2005 | EP1519908A2 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 04/06/2005 | EP1519754A1 Use of cetp inhibitors and optionally hmg coa reductase inhibitors and/or antihypertensive agents |
| 04/06/2005 | EP1519749A1 Chemotactic factor inhibitor for modulating inflammatory reactions |
| 04/06/2005 | EP1519746A1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
| 04/06/2005 | EP1519733A1 Compositions for cancer therapy comprising saponins or sapogenins |
| 04/06/2005 | EP1519731A1 Combination of azelastine and steroids |
| 04/06/2005 | EP1519727A1 4-(4-methylpiperazin-1-ylmethyl)-n- 4-methyl-3-(4-pyridin-3- yl)pyrimidin-2-ylamino)phenyl -benzamide for treating pulmon ary fibrosis |
| 04/06/2005 | EP1519719A1 Methods for the treatment of sinusitis |
| 04/06/2005 | EP1353909B1 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents |
| 04/06/2005 | EP1334086B1 Phenoxyphenyl alkane sulfonates |
| 04/06/2005 | EP1307455B1 Inhibitors of alpha-l beta-2 mediated cell adhesion |
| 04/06/2005 | EP1299409B1 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 04/06/2005 | EP1140062B1 Treatment of asthma with mek inhibitors |
| 04/06/2005 | EP1077700B1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE |
| 04/06/2005 | EP1040190B1 Serine proteinase inhibitors |
| 04/06/2005 | EP0960096B1 Substituted beta-thiocarboxylic acids |
| 04/06/2005 | EP0933366B1 5-phenyl-3-pyridazinone derivatives and drug compositions containing the same |
| 04/06/2005 | EP0912521B1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
| 04/06/2005 | EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/06/2005 | CN1604909A Cyclic peptides as g-protein-coupled receptor antagonists |
| 04/06/2005 | CN1604904A Phosphonic acid compounds as inhibitors of serine proteases |
| 04/06/2005 | CN1604901A Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/06/2005 | CN1604900A 6-aminomorphinane derivatives, method for production and use thereof |
| 04/06/2005 | CN1604898A 3-heteroaryl-3, 5-dihydro-4-oxo-4h-pyridazino[4, 5-b]indole-1-carboxamide derivatives, their preparation, their intermediates and pharmaceutical compositions containing the compounds |
| 04/06/2005 | CN1604897A 7-amino-benzothiazole derivatives as adenosine receptor ligands |
| 04/06/2005 | CN1604893A Cyclic amine compounds |
| 04/06/2005 | CN1604795A Combination motif immune stimulatory oligonucleotides with improved activity |
| 04/06/2005 | CN1604783A Drug for treating a fibrotic disease through rna interfence |
| 04/06/2005 | CN1604773A Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine |
| 04/06/2005 | CN1603346A Protein, products containing same, and their use in diagnosis, treatment and /or prevention of SARS related disease |
| 04/06/2005 | CN1603314A Pyrazolobenzodiazepines as CDK2 inhibitors |
| 04/06/2005 | CN1603291A Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 04/06/2005 | CN1602956A Deactivated BCG for treating disease |
| 04/06/2005 | CN1602946A Buccal tablets for treating acute and chronic pharyngitis and stomatitis and its preparation process |
| 04/06/2005 | CN1602945A Rhinitis treating soft medicinal capsule and preparation process thereof |
| 04/06/2005 | CN1602936A Application of golden buckwheat rhizome in the preparing process of medicine for treating respiratory syncytial virus infected disease |
| 04/06/2005 | CN1602924A Chinese medicinal composition for treating bronchitis and preparing method thereof |
| 04/06/2005 | CN1602920A Gingko leaf extracts with superior quality and its manufacturing technique |
| 04/06/2005 | CN1602918A Astragalus root and Breviscapine containing Chinese medicinal formulation and its preparation and application |